ADMA Biologics Inc vs Blackstone Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Blackstone Inc trades at $147.89 (market cap $117.44B). The key difference: Blackstone Inc is far larger — about 52.9× ADMA Biologics Inc's market cap, and Blackstone Inc pays a 3.55% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | BX | |
|---|---|---|
Market Cap | $2.22B | $117.44B |
Sector | Health | Financials |
52-Week High | $20.38 | $188.68 |
52-Week Low | $7.60 | $102.12 |
Enterprise Value | $2.29B | — |
Dividend Yield | — | 3.55% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →